D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
NVIDIA
NVDA
|
+$1.27B |
| 2 |
Meta Platforms (Facebook)
META
|
+$728M |
| 3 |
Microsoft
MSFT
|
+$524M |
| 4 |
T-Mobile US
TMUS
|
+$411M |
| 5 |
Uber
UBER
|
+$406M |
Top Sells
| 1 |
Visa
V
|
+$567M |
| 2 |
Charles Schwab
SCHW
|
+$531M |
| 3 |
Apple
AAPL
|
+$484M |
| 4 |
Johnson & Johnson
JNJ
|
+$455M |
| 5 |
Accenture
ACN
|
+$401M |
Sector Composition
| 1 | Technology | 25.5% |
| 2 | Consumer Discretionary | 13.42% |
| 3 | Healthcare | 12.98% |
| 4 | Financials | 9.15% |
| 5 | Industrials | 7.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2476
Cavco Industries
CVCO
$4.28B
| $206K | ﹤0.01% |
699
-122
| -15% | -$36K |
|
2477
Visteon
VC
$3.42B
| $205K | ﹤0.01% |
1,426
-167
| -10% | -$24K |
|
|
SA
2478
Seabridge Gold
SA
$1.8B
| $205K | ﹤0.01% |
+16,980
| New | +$205K |
|
2479
CorMedix
CRMD
$977M
| $203K | ﹤0.01% |
51,304
-75,005
| -59% | -$297K |
|
2480
Arcus Biosciences
RCUS
$1.25B
| $203K | ﹤0.01% |
+9,995
| New | +$203K |
|
2481
Nuvation Bio
NUVB
$1.15B
| $202K | ﹤0.01% |
112,236
+32,535
| +41% | +$58.6K |
|
|
VCXB
2482
DELISTED
10X Capital Venture Acquisition Corp. III
VCXB
| $202K | ﹤0.01% |
+19,251
| New | +$202K |
|
|
NEX
2483
DELISTED
NexTier Oilfield Solutions Inc.
NEX
| $201K | ﹤0.01% |
22,460
-105,886
| -83% | -$947K |
|
2484
American Homes 4 Rent
AMH
$12.7B
| $200K | ﹤0.01% |
+5,655
| New | +$200K |
|
2485
Sandstorm Gold
SAND
$3.44B
| $200K | ﹤0.01% |
39,100
+17,700
| +83% | +$90.7K |
|
|
CFB
2486
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
| $200K | ﹤0.01% |
19,950
-12,513
| -39% | -$125K |
|
2487
Generation Bio
GBIO
$40.3M
| $199K | ﹤0.01% |
3,624
-4,628
| -56% | -$255K |
|
2488
Rocket Lab Corporation Common Stock
RKLB
$23.4B
| $198K | ﹤0.01% |
32,930
-2,390
| -7% | -$14.3K |
|
2489
The ONE Group
STKS
$82.3M
| $197K | ﹤0.01% |
26,861
-2,353
| -8% | -$17.2K |
|
2490
Macy's
M
$4.67B
| $195K | ﹤0.01% |
12,164
-1,289,085
| -99% | -$20.7M |
|
2491
Universal Technical Institute
UTI
$1.48B
| $194K | ﹤0.01% |
28,022
-4,021
| -13% | -$27.8K |
|
2492
A10 Networks
ATEN
$1.26B
| $192K | ﹤0.01% |
+13,145
| New | +$192K |
|
2493
Turkcell
TKC
$4.79B
| $190K | ﹤0.01% |
53,353
+37,502
| +237% | +$134K |
|
|
VXRT
2494
DELISTED
Vaxart
VXRT
| $189K | ﹤0.01% |
259,516
-721,867
| -74% | -$527K |
|
2495
Sutro Biopharma
STRO
$77.2M
| $189K | ﹤0.01% |
40,723
-114,476
| -74% | -$532K |
|
2496
ClearPoint Neuro
CLPT
$299M
| $188K | ﹤0.01% |
+25,973
| New | +$188K |
|
2497
Senseonics Holdings
SENS
$371M
| $186K | ﹤0.01% |
244,101
-73,473
| -23% | -$56.1K |
|
2498
Solid Power, Inc. Warrant
SLDPW
$86.7M
| $185K | ﹤0.01% |
604,873
| – | – |
|
|
KNTE
2499
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $182K | ﹤0.01% |
+60,109
| New | +$182K |
|
2500
Adtran
ADTN
$849M
| $181K | ﹤0.01% |
+17,152
| New | +$181K |
|